history
TOP＞Corporate Information＞History
| 1975 | September October |
The Company founded in Kobe, Japan Mikage Plant established at Higashinada-ku, Kobe |
|---|---|---|
| 1976 | December | Development of purification method of Urokinase |
| 1977 | April | Research Laboratories established at Higashinada-ku, Kobe |
| 1983 | October | Manufacture of Urokinase product and bulk approved |
| 1985 | January | Import of human Growth Hormone (hGH) approved in Japan |
| 1986 | June December |
Seishin Plant established at Nishi-ku, Kobe Research Institute established at Nishi-ku, Kobe |
| 1992 | October | IPO (listed on the over-the-counter stock market in Japan) |
| 1993 | April October |
Manufacture of recombinant hGH product, Growject® Inj. 4IU, approved Research Laboratories established in northwest Kobe |
| 1994 | March | Manufacture of Ulinastatin bulk substance approved |
| 1995 | March | Listed on the Second Section of the Osaka Securities Exchange |
| 1997 | October | Alliance established with Mochida Pharmaceutical Co., Ltd. for supply of urine-derived products. |
| 1999 | January AprilOctober December |
Alliance established with Sumitomo Pharmaceuticals Co., Ltd. (current Sumitomo Pharma Co., Ltd.) for co-marketing of Growject® Inj. 4IU Manufacture of Macrophage Colony Stimulating Factor, Leucoprol®, started Marketing approval of Growject® 8mg Growject® approval expanded for Turner indication |
| 2000 | May July |
Kobe Plant established in northwest Kobe Growject® 8mg and Growject Pen launched |
| 2003 | August | Alliance established with Osiris Therapeutics, Inc. (USA) for its technology on the use and manufacture of human mesenchymal stem cells |
| 2006 | October | GROWJECTOR® , a motorized digital injector for Growject® injection, launched |
| 2008 | April | Murotani Plant established at northwest Kobe |
| 2009 | July | Growject® approval expanded for adult growth hormone deficiency |
| 2010 | January | Marketing approval of “Epoetin alfa BS Inj. JCR” obtained in Japan for treatment of renal anemia |
| 2011 | March | Listed on the Second Section of the Tokyo Stock Exchange |
| 2012 |
July August |
GROWJECTOR®2 , a motorized digital injector for Growject® injection, launched Growject® approval expanded for short stature associated with small for gestational age |
| 2013 |
May November |
Kobe API Plant established at northwest Kobe Listed on the First Section of the Tokyo Stock Exchange |
| 2014 | January | Japanese corporate name changed to "JCRファーマ" |
| 2015 | September | Marketing approval of TEMCELL® HS Inj., The first Allogeneic Regenerative Medicine in Japan |
| 2016 |
April August |
Clinical Trial Material Manufacturing Center and Cell Processing Center established at northwest Kobe Marketing approval for a new liquid formulation of Growject® |
| 2017 |
January September |
GROWJECTOR®L , a motorized digital injector for Growject® injection, launched Business and Capital Alliance agreement conducted with MEDIPAL HOLDINGS CORPORATION |
| 2018 | January September |
JCR USA, Inc. established Marketing Approval of “Agalsidase Beta BS I.V. Infusion JCR” for Fabry disease |
| 2019 | September | Marketing Approval of “Darbepoetin Alfa BS Injection JCR”, a Long-Acting Erythropoiesis-Stimulating Agent. |
| 2020 | April September |
Acquire ArmaGen, Inc. JCR DO BRASIL FARMACÊUTICOS IMPORTAÇÃO E EXPORTAÇÃO LTDA. began business activities. |
| 2021 | January March |
Bioresearch Center has initiated operation at northwest Kobe Marketing Approval of “IZCARGO®” for Mucopolysaccharidosis type II |
| 2022 |
April August September October November |
Transition to the Prime Market in the Tokyo Stock Exchange New Market Segments JCR Luxembourg S.A. established JCR Europe B.V. began business activities. AlliedCel Corporation established Kobe Science Park Center established at northwest Kobe |
| 2023 |
April June August |
Alliance established with Sumitomo Pharma Co., Ltd. For Co-Promotion Agreement in Japan for IZCARGO® I.V. Infusion 10 mg, a Recombinant Therapeutic for Mucopolysaccharidosis Type Ⅱ Growject® approval expanded for Short Stature due to SHOX-Deficiency GROWJECTOR® Duo, a motorized digital injector for Growject® injection, launched |